These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12616033)
21. Changes of the cardiac architectures and functions for chronic hemodialysis patients with dry weight determined by echocardiography. Chang ST; Chen CC; Chen CL; Cheng HW; Chung CM; Yang TY Blood Purif; 2004; 22(4):351-9. PubMed ID: 15297785 [TBL] [Abstract][Full Text] [Related]
22. Echography of left ventricular end-diastolic diameter as a reliable tool for estimating "dry weight" in hemodialysis patients. Yoshimura R; Goto T; Tsuchida K; Takemoto Y; Wada S; Sano H; Kishimoto T; Yamamoto K; Nakatani T Ren Fail; 2003 Jan; 25(1):31-41. PubMed ID: 12617331 [TBL] [Abstract][Full Text] [Related]
23. Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. Tripepi G; Mattace-Raso F; Mallamaci F; Benedetto FA; Witteman J; Malatino L; Zoccali C Hypertension; 2009 Oct; 54(4):818-24. PubMed ID: 19635983 [TBL] [Abstract][Full Text] [Related]
24. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Haug C; Metzele A; Steffgen J; Grünert A Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909 [TBL] [Abstract][Full Text] [Related]
25. Influence of renal function on serum and urinary heart fatty acid-binding protein levels. Nayashida N; Chihara S; Tayama E; Akasu K; Kai E; Kawara T; Aoyagi S J Cardiovasc Surg (Torino); 2001 Dec; 42(6):735-40. PubMed ID: 11698938 [TBL] [Abstract][Full Text] [Related]
26. Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease. Buiten MS; de Bie MK; Rotmans JI; Dekker FW; van Buren M; Rabelink TJ; Cobbaert CM; Schalij MJ; van der Laarse A; Jukema JW PLoS One; 2015; 10(8):e0134245. PubMed ID: 26237313 [TBL] [Abstract][Full Text] [Related]
27. Brain natriuretic peptide in hemodialysis patients: predictive value for hemodynamic change during hemodialysis and cardiac function. Matayoshi T; Kato T; Nakahama H; Nakata H; Yoshihara F; Kamide K; Horio T; Nakamura S; Kawano Y Am J Nephrol; 2008; 28(1):122-7. PubMed ID: 17943021 [TBL] [Abstract][Full Text] [Related]
29. Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis. Ishikura F; Ando Y; Park YD; Tani A; Shirai D; Matsuoka H; Miyatake K Ren Fail; 1996 Mar; 18(2):261-70. PubMed ID: 8723364 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403 [TBL] [Abstract][Full Text] [Related]
31. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease. Osajima A; Okazaki M; Tamura M; Anai H; Kabashima N; Suda T; Iwamoto M; Ota T; Watanabe Y; Kanegae K; Nakashima Y Nephron; 2002 Dec; 92(4):832-9. PubMed ID: 12399629 [TBL] [Abstract][Full Text] [Related]
32. [Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients]. Shao YH; Lai YQ; Lin AZ; Kong YZ Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):892-4. PubMed ID: 16027094 [TBL] [Abstract][Full Text] [Related]
33. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760 [TBL] [Abstract][Full Text] [Related]
34. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Lee SW; Song JH; Kim GA; Lim HJ; Kim MJ Am J Kidney Dis; 2003 Jun; 41(6):1257-66. PubMed ID: 12776279 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker? Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of heart fatty acid binding protein and myoglobin in patients admitted with chest pain. Alansari SE; Croal BL Ann Clin Biochem; 2004 Sep; 41(Pt 5):391-6. PubMed ID: 15333191 [TBL] [Abstract][Full Text] [Related]
39. The prognostic role of brain natriuretic peptides in hemodialysis patients. Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941 [TBL] [Abstract][Full Text] [Related]